MeFirst: A Tailored Intervention to HPV Vaccine Decision Making

University of Michigan

Status: Completed

Conditions: Human Papillomavirus-Related Carcinoma

Treatments: Behavioral: MeFirst Tailored Intervention

Study type: Interventional

Funder types: Other

Identifiers

NCT01769560

HUM00069032

Details and patient eligibility

About

This study will test whether a tailored, online educational intervention increases HPV vaccine uptake and intent among female college students.

Full description

MeFirst is the first web-based, online, educational tool designed to promote Human Papillomavirus (HPV) vaccine awareness and understanding in an effort to improve HPV vaccine intent and uptake among female university students. HPV is the most common sexually transmitted infection and causes genital warts and cancer. The HPV vaccine has been recommended for girls ages 11-26 since 2006, yet vaccination rates remain low. Tailored online interventions may be more effective tools to promote behavior change among college students than traditional static interventions. The proposed study is a randomized controlled trial testing the efficacy of the MeFirst tool vs. standard static educational material on increasing HPV vaccination intent and uptake among female university students aged 18-26.

Enrollment: 661 patients

Sex: Female

Ages: 18 to 26 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• enrolled at the University of Michigan

Exclusion criteria

• receipt of any doses of HPV vaccine

Trial design

Primary purpose: Health Services Research

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: Double Blind

---

661 participants in 2 patient groups

Centers for Disease Control and Prevention (CDC) Fact Sheet

No Intervention group

Description:

Participants will receive the CDC Fact sheet about HPV vaccination while they are taking the survey.

MeFirst Intervention

Experimental group

Description:

Participants will receive a tailored website regarding their own individualized risk for HPV and information about HPV Vaccination while they are taking the survey as opposed to receiving the CDC fact sheet. This tailored website is generated based on answers provided by each subject in the baseline survey.

Treatment:

Behavioral: MeFirst Tailored Intervention